Notice: This company has been marked as potentially delisted and may not be actively trading. Champions Oncology (CSBR) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrends Champions Oncology Short Interest DataChampions Oncology (CSBR) has a short interest of 98,800 shares, representing 1.62% of the float (the number of shares available for trading by the public). This marks a -5.27% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 44,320 shares to cover all short positions.Current Short Interest98,800 sharesPrevious Short Interest104,300 sharesChange Vs. Previous Month-5.27%Dollar Volume Sold Short$1.09 millionShort Interest Ratio1.7 Days to CoverLast Record DateFebruary 15, 2025Outstanding Shares13,820,000 sharesFloat Size6,100,000 sharesShort Percent of Float1.62%Today's Trading Volume32,633 sharesAverage Trading Volume44,320 sharesToday's Volume Vs. Average74% Short Selling Champions Oncology? Sign up to receive the latest short interest report for Champions Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCSBR Short Interest Over TimeCSBR Days to Cover Over TimeCSBR Percentage of Float Shorted Over Time Champions Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/202598,800 shares $1.09 million -5.3%1.6%1.7 $11.01 1/31/2025104,300 shares $1.15 million -4.2%1.7%2 $10.99 1/15/2025108,900 shares $1.05 million -38.3%1.8%2.3 $9.67 12/31/2024176,400 shares $1.52 million -22.0%3.0%4.3 $8.62 12/15/2024226,000 shares $1.43 million +3.7%3.8%7.3 $6.33 11/30/2024217,900 shares $984,908.00 -2.9%3.7%3.9 $4.52 11/15/2024224,500 shares $996,780.00 +18.5%3.8%4.2 $4.44 10/31/2024189,500 shares $740,945.00 -5.3%3.2%3.6 $3.91 10/15/2024200,100 shares $908,454.00 -8.1%3.4%3.9 $4.54 9/30/2024217,700 shares $1.06 million -33.6%3.6%4.4 $4.87 Get the Latest News and Ratings for CSBR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Champions Oncology and its competitors with MarketBeat's FREE daily newsletter. 9/15/2024327,700 shares $1.65 million +555.4%5.5%6.9 $5.05 8/31/202450,000 shares $211,000.00 +3.3%0.8%8.5 $4.22 8/15/202448,400 shares $217,800.00 No Change0.8%7.6 $4.50 7/31/202448,400 shares $237,644.00 -1.4%0.8%6.4 $4.91 7/15/202449,100 shares $247,955.00 -1.0%0.8%6.5 $5.05 6/30/202449,600 shares $256,432.00 -5.0%0.8%6.9 $5.17 6/15/202452,200 shares $262,566.00 -1.9%0.9%7.2 $5.03 5/31/202453,200 shares $240,996.00 -5.2%0.9%7 $4.53 5/15/202456,100 shares $261,987.00 -6.0%0.9%11.2 $4.67 4/30/202459,700 shares $298,500.00 +5.7%1.0%16.1 $5.00 4/15/202456,500 shares $284,195.00 -2.8%0.9%13.8 $5.03 3/31/202458,100 shares $284,690.00 -7.2%1.0%8.3 $4.90 3/15/202462,600 shares $342,422.00 -3.0%1.0%6 $5.47 2/29/202464,500 shares $365,070.00 +1.7%1.1%5.5 $5.66 2/15/202463,400 shares $359,478.00 -6.6%1.0%5.4 $5.67 1/31/202467,900 shares $394,499.00 +6.1%1.1%5.5 $5.81 1/15/202464,000 shares $429,440.00 -5.7%1.1%5 $6.71 12/31/202367,900 shares $381,591.21 -16.8%1.1%6.1 $5.62 12/15/202381,600 shares $376,176.00 +16.9%1.4%8 $4.61 11/30/202369,800 shares $359,470.00 -1.7%1.2%7.9 $5.15 11/15/202371,000 shares $390,500.00 -2.6%1.2%8.7 $5.50 10/31/202372,900 shares $398,034.00 -6.9%0.7%8.7 $5.46 10/15/202378,300 shares $481,545.00 +5.4%0.8%9.2 $6.15 9/30/202374,300 shares $461,403.00 +25.3%0.7%9.1 $6.21 9/15/202359,300 shares $311,325.00 +3.0%0.6%7.4 $5.25 8/31/202357,600 shares $385,920.00 -22.8%0.6%7 $6.70 8/15/202374,600 shares $484,154.00 -5.1%1.4%8.4 $6.49 7/31/202378,600 shares $510,900.00 +14.9%1.5%8.6 $6.50 7/15/202368,400 shares $452,151.36 +1.5%1.3%8 $6.61 6/30/202367,400 shares $430,012.00 -4.3%1.2%6.9 $6.38Elon’s “New Gold” (Ad)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.I reveal all of the details here. 6/15/202370,400 shares $387,904.00 -25.6%1.3%6.9 $5.51 5/31/202394,600 shares $463,540.00 +67.7%1.7%8.9 $4.90 5/15/202356,400 shares $250,416.00 -0.5%1.0%5.2 $4.44 4/30/202356,700 shares $278,964.00 -10.6%1.0%5.3 $4.92 4/15/202363,400 shares $304,320.00 +6.0%1.2%5.2 $4.80 3/31/202359,800 shares $240,396.00 +4.0%1.1%4.6 $4.02 3/15/202357,500 shares $235,750.00 -1.2%1.1%3.5 $4.10 2/28/202358,200 shares $270,630.00 +3.2%1.1%2.6 $4.65 2/15/202356,400 shares $232,368.00 +0.5%1.0%2.5 $4.12 1/31/202356,100 shares $230,571.00 +6.3%1.0%2.4 $4.11 1/15/202352,800 shares $227,040.00 -14.0%1.0%2.3 $4.30 12/30/202261,400 shares $276,914.00 -2.4%1.1%3 $4.51 12/15/202262,900 shares $345,950.00 -2.5%1.2%3.2 $5.50 11/30/202264,500 shares $445,050.00 +7.0%1.2%7.2 $6.90 11/15/202260,300 shares $386,523.00 -9.3%1.1%6.6 $6.41 10/31/202266,500 shares $461,510.00 -1.6%1.2%7.2 $6.94 10/15/202267,600 shares $508,352.00 -2.5%1.3%7.5 $7.52 9/30/202269,300 shares $519,750.00 -10.9%1.1%6.8 $7.50 9/15/202277,800 shares $680,750.00 +22.7%1.3%7.9 $8.75 8/31/202263,400 shares $505,932.00 -3.4%1.0%8.7 $7.98 8/15/202265,600 shares $616,640.00 +15.5%1.1%9.9 $9.40 7/31/202256,800 shares $491,888.00 +4.2%1.3%10.7 $8.66 7/15/202254,500 shares $443,624.55 -18.9%1.3%12.4 $8.14 6/30/202267,200 shares $537,606.72 +13.9%1.6%24 $8.00 6/15/202259,000 shares $443,090.00 -22.3%1.4%15.1 $7.51 5/31/202275,900 shares $561,660.00 +16.4%1.3%14.9 $7.40 5/15/202265,200 shares $487,696.00 +12.2%1.1%10.5 $7.48 4/30/202258,100 shares $446,208.00 No Change1.0%8.7 $7.68 4/15/202258,100 shares $479,906.00 -4.9%1.0%8.2 $8.26 3/31/202261,100 shares $496,743.00 -7.1%1.0%8 $8.13 3/15/202265,800 shares $499,422.00 +10.0%1.1%8.7 $7.59 2/28/202259,800 shares $469,430.00 -0.5%1.0%8.4 $7.85 2/15/202260,100 shares $464,573.00 -4.0%1.0%8.6 $7.73 1/31/202262,600 shares $502,052.00 -3.5%1.0%8.9 $8.02 1/15/202264,900 shares $521,147.00 +0.6%1.1%8.8 $8.03 12/31/202164,500 shares $539,220.00 -3.6%1.1%8.4 $8.36 12/15/202166,900 shares $524,496.00 -8.0%1.1%8.5 $7.84 11/30/202172,700 shares $575,784.00 +8.5%1.2%6.2 $7.92 11/15/202167,000 shares $661,290.00 -5.9%1.1%2.7 $9.87 10/29/202171,200 shares $695,624.00 +2.5%1.2%2.8 $9.77 10/15/202169,500 shares $700,560.00 +5.1%1.2%2.5 $10.08 9/30/202166,100 shares $674,881.00 -6.8%1.1%2.2 $10.21 9/15/202170,900 shares $745,159.00 +11.0%1.2%1.5 $10.51 8/31/202163,900 shares $619,191.00 -5.3%1.1%1.3 $9.69 8/13/202167,500 shares $728,325.00 -2.0%1.0%1.7 $10.79 7/30/202168,900 shares $720,005.00 -11.6%1.2%1.7 $10.45 7/15/202177,900 shares $736,934.00 -11.2%1.3%1.8 $9.46 6/30/202187,700 shares $901,556.00 -77.3%1.3%2.1 $10.28 6/15/2021385,800 shares $3.68 million +6.0%9.3%14 $9.54 5/28/2021364,100 shares $3.43 million +0.6%8.8%13 $9.41Elon’s “New Gold” (Ad)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.I reveal all of the details here. 5/14/2021362,000 shares $3.28 million +16.6%8.7%11.8 $9.07 4/30/2021310,400 shares $3.49 million +78.3%7.5%9.4 $11.25 4/15/2021174,100 shares $2.01 million +9.1%4.2%5.4 $11.53 3/31/2021159,600 shares $1.84 million +10.6%3.9%4.9 $11.50 3/15/2021144,300 shares $1.72 million -6.2%3.5%4 $11.89 2/26/2021153,800 shares $1.76 million +9.7%3.8%4.2 $11.46 2/12/2021140,200 shares $1.65 million +7.1%3.4%4 $11.76 1/29/2021130,900 shares $1.48 million +6.5%2.0%3.8 $11.33 1/15/2021122,900 shares $1.38 million No Change1.9%3.4 $11.23 CSBR Short Interest - Frequently Asked Questions What is Champions Oncology's current short interest? Short interest is the volume of Champions Oncology shares that have been sold short but have not yet been covered or closed out. As of February 15th, investors have sold 98,800 shares of CSBR short. 1.62% of Champions Oncology's shares are currently sold short. Learn More on Champions Oncology's current short interest. What is a good short interest ratio for Champions Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CSBR shares currently have a short interest ratio of 2.0. Learn More on Champions Oncology's short interest ratio. Which institutional investors are shorting Champions Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Champions Oncology: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Champions Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.62% of Champions Oncology's floating shares are currently sold short. Is Champions Oncology's short interest increasing or decreasing? Champions Oncology saw a decrease in short interest in the month of February. As of February 15th, there was short interest totaling 98,800 shares, a decrease of 5.3% from the previous total of 104,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Champions Oncology's float size? Champions Oncology currently has issued a total of 13,820,000 shares. Some of Champions Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Champions Oncology currently has a public float of 6,100,000 shares. How does Champions Oncology's short interest compare to its competitors? 1.62% of Champions Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Champions Oncology: MeiraGTx Holdings plc (2.86%), Immatics (7.64%), Cullinan Therapeutics, Inc. (24.56%), Autolus Therapeutics plc (4.80%), Allogene Therapeutics, Inc. (24.98%), ProKidney Corp. (12.78%), Compass Therapeutics, Inc. (4.40%), Humacyte, Inc. (23.07%), Tectonic Therapeutic (10.27%), Aura Biosciences, Inc. (2.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks. What does it mean to sell short Champions Oncology stock? Short selling CSBR is an investing strategy that aims to generate trading profit from Champions Oncology as its price is falling. CSBR shares are trading up $0.64 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Champions Oncology? A short squeeze for Champions Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CSBR, which in turn drives the price of the stock up even further. How often is Champions Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CSBR, twice per month. The most recent reporting period available is February, 15 2025. More Short Interest Resources from MarketBeat Related Companies MeiraGTx Short Squeeze Immatics Short Squeeze Cullinan Therapeutics Short Squeeze Autolus Therapeutics Short Squeeze Allogene Therapeutics Short Squeeze ProKidney Short Squeeze Compass Therapeutics Short Squeeze Humacyte Short Squeeze Tectonic Therapeutic Short Squeeze Aura Biosciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CSBR) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Champions Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Champions Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
